A 24–week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults - Halvorsen, Y D; Lock, J P; Zhou, W (Diabetes, Obesity and Metabolism, 2019)